Skip to content
← Back to this collection

PUBLICATIONS · 27211272

Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2016 Aug
First author
Harrison CN

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Leukemia. 2017 Mar;31(3):775. doi: 10.1038/leu.2016.323.
    note
    Source null
    related pmid
    28248313
    relationship
    Erratum in

Authors and identifiers

  1. name
    Harrison CN
    type
    Author
  2. name
    Vannucchi AM
    type
    Author
  3. name
    Kiladjian JJ
    type
    Author
  4. name
    Al-Ali HK
    type
    Author
  5. name
    Gisslinger H
    type
    Author
  6. name
    Knoops L
    type
    Author
  7. name
    Cervantes F
    type
    Author
  8. name
    Jones MM
    type
    Author
  9. name
    Sun K
    type
    Author
  10. name
    McQuitty M
    type
    Author
  11. name
    Stalbovskaya V
    type
    Author
  12. name
    Gopalakrishna P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Harrison CN
    type
    Author
  2. name
    Vannucchi AM
    type
    Author
  3. name
    Kiladjian JJ
    type
    Author
  4. name
    Al-Ali HK
    type
    Author
  5. name
    Gisslinger H
    type
    Author
  6. name
    Knoops L
    type
    Author
  7. name
    Cervantes F
    type
    Author
  8. name
    Jones MM
    type
    Author
  9. name
    Sun K
    type
    Author
  10. name
    McQuitty M
    type
    Author
  11. name
    Stalbovskaya V
    type
    Author
  12. name
    Gopalakrishna P
    type
    Author
bibliography ids
  1. nci-bib-cfc48b0c4dd802cd6c4a9deb
book metadata
content sha256
2e730ac5fc3f8644d92aa7406ded9bdd0d358db69e38ceb32078cbb3fd6fa88d
document type
citation
dois
  1. 10.1038/leu.2016.148
electronic publication date
display
2016 May 23
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27211272
immutable id
pubmed:27211272@2e730ac5fc3f8644d92aa7406ded9bdd0d358db69e38ceb32078cbb3fd6fa88d
journal
abbreviation
Leukemia
issn electronic
1476-5551
issn print
0887-6924
issue
8
name
Leukemia
nlm unique id
8704895
pages
1701-7
volume
30
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Leukemia. 2017 Mar;31(3):775. doi: 10.1038/leu.2016.323.
    note
    Source null
    related pmid
    28248313
    relationship
    Erratum in
outcomes validated
false
pmid
27211272
provenance
batch id
fe5a46c92522c34737e8
provider
NCBI PubMed ESummary
record sha256
adc82996a115292c69b3977cfa38ffcd2d87f7d17007d9da570b36f7b9498e05
response sha256
2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
retrieved at
2026-09-09T23:47:17.939307+00:00
publication date
display
2016 Aug
precision
month
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27211272/
title
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.

Preserved source evidence · Not medical advice